Loading page content…
Loading page content…
10 matching contracts · Updated daily · Contracts Finder + Find a Tender Service
Provider Selection Regime (PSR) Direct Award Process C for Provision of Stem Cell Storage and Destruction Services to Barts NHS Trust. The contract is for the continued provision of Stem Cell Storage and Destruction Services. The service includes stem cell storage and destruction services. It forms part of the Trust’s pathology framework and ensures continuity of care. This award is being made under Provider Selection Regime Direct Award C to an existing provider to Barts NHS Trust. The appropriate lifetime value of the contract is £290,000 The contract will be provisioned from 01/06/2025 till 31/08/2026. Award criteria All five PSR Key Criteria have been evaluated and documented internally. Justification for Direct Award under Procedure C: • The provider is the current incumbent and has delivered the service to a high standard. • Their service is fully integrated into the patient care pathway. • The service has been demonstrated to be value for money. • No alternative provider is likely to offer better outcomes on quality, value, or integration. • All five PSR Key Criteria have been evaluated and documented internally. • Samples cannot be moved Award of a contract without prior publication of a call for competition in the cases listed below The procurement falls outside the scope of application of the regulations - Public Contracts Regulations 2015/Procurement Act 2023. Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has not yet formally been awarded. This notice serves as an intention to award under the PSR. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 22/05/2025 Any written representations should be made to - victoria.sullivan11@nhs.net Decision makers in this award included: Victoria Sullivan (Procurement Business Partner) Jodi Chapman (Procurement Business Partner) Contract Award to: • Legal Name: Thermo Electron Limited, trading as Fisher Bioservices UK • Company Registration Number: 1735858 • Registered Office Address: 1 Woodside, Bishops Stortford, Herts CM23 5RG • Principal Place of Business: Same as registered office
Value undisclosed
Provider Selection Regime (PSR) Direct Award Process C for Provision of Stem Cell Storage and Destruction Services to Barts NHS Trust. The contract is for the continued provision of Stem Cell Storage and Destruction Services. The service includes stem cell storage and destruction services. It forms part of the Trust’s pathology framework and ensures continuity of care. This award is being made under Provider Selection Regime Direct Award C to an existing provider to Barts NHS Trust. The appropriate lifetime value of the contract is £290,000 The contract will be provisioned from 01/06/2025 till 31/08/2026. Award criteria All five PSR Key Criteria have been evaluated and documented internally. Justification for Direct Award under Procedure C: • The provider is the current incumbent and has delivered the service to a high standard. • Their service is fully integrated into the patient care pathway. • The service has been demonstrated to be value for money. • No alternative provider is likely to offer better outcomes on quality, value, or integration. • All five PSR Key Criteria have been evaluated and documented internally. • Samples cannot be moved Award of a contract without prior publication of a call for competition in the cases listed below The procurement falls outside the scope of application of the regulations - Public Contracts Regulations 2015/Procurement Act 2023. Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has not yet formally been awarded. This notice serves as an intention to award under the PSR. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 22/05/2025 Any written representations should be made to - victoria.sullivan11@nhs.net Decision makers in this award included: Victoria Sullivan (Procurement Business Partner) Jodi Chapman (Procurement Business Partner) Contract Award to: • Legal Name: Thermo Electron Limited, trading as Fisher Bioservices UK • Company Registration Number: 1735858 • Registered Office Address: 1 Woodside, Bishops Stortford, Herts CM23 5RG • Principal Place of Business: Same as registered office
Value undisclosed
Provider Selection Regime (PSR) Direct Award Process C for Provision of Stem Cell Storage and Destruction Services to Barts NHS Trust. The contract is for the continued provision of Stem Cell Storage and Destruction Services. The service includes stem cell storage and destruction services. It forms part of the Trust’s pathology framework and ensures continuity of care. This award is being made under Provider Selection Regime Direct Award C to an existing provider to Barts NHS Trust. The appropriate lifetime value of the contract is £290,000 The contract will be provisioned from 01/06/2025 till 31/08/2026. Award criteria All five PSR Key Criteria have been evaluated and documented internally. Justification for Direct Award under Procedure C: • The provider is the current incumbent and has delivered the service to a high standard. • Their service is fully integrated into the patient care pathway. • The service has been demonstrated to be value for money. • No alternative provider is likely to offer better outcomes on quality, value, or integration. • All five PSR Key Criteria have been evaluated and documented internally. • Samples cannot be moved Award of a contract without prior publication of a call for competition in the cases listed below The procurement falls outside the scope of application of the regulations - Public Contracts Regulations 2015/Procurement Act 2023. Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has not yet formally been awarded. This notice serves as an intention to award under the PSR. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 22/05/2025 Any written representations should be made to - victoria.sullivan11@nhs.net Decision makers in this award included: Victoria Sullivan (Procurement Business Partner) Jodi Chapman (Procurement Business Partner) Contract Award to: • Legal Name: Thermo Electron Limited, trading as Fisher Bioservices UK • Company Registration Number: 1735858 • Registered Office Address: 1 Woodside, Bishops Stortford, Herts CM23 5RG • Principal Place of Business: Same as registered office
Value undisclosed
Provider Selection Regime (PSR) Direct Award Process C for Provision of Stem Cell Storage and Destruction Services to Barts NHS Trust. The contract is for the continued provision of Stem Cell Storage and Destruction Services. The service includes stem cell storage and destruction services. It forms part of the Trust’s pathology framework and ensures continuity of care. This award is being made under Provider Selection Regime Direct Award C to an existing provider to Barts NHS Trust. The appropriate lifetime value of the contract is £290,000 The contract will be provisioned from 01/06/2025 till 31/08/2026. Award criteria All five PSR Key Criteria have been evaluated and documented internally. Justification for Direct Award under Procedure C: • The provider is the current incumbent and has delivered the service to a high standard. • Their service is fully integrated into the patient care pathway. • The service has been demonstrated to be value for money. • No alternative provider is likely to offer better outcomes on quality, value, or integration. • All five PSR Key Criteria have been evaluated and documented internally. • Samples cannot be moved Award of a contract without prior publication of a call for competition in the cases listed below The procurement falls outside the scope of application of the regulations - Public Contracts Regulations 2015/Procurement Act 2023. Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has not yet formally been awarded. This notice serves as an intention to award under the PSR. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 22/05/2025 Any written representations should be made to - victoria.sullivan11@nhs.net Decision makers in this award included: Victoria Sullivan (Procurement Business Partner) Jodi Chapman (Procurement Business Partner) Contract Award to: • Legal Name: Thermo Electron Limited, trading as Fisher Bioservices UK • Company Registration Number: 1735858 • Registered Office Address: 1 Woodside, Bishops Stortford, Herts CM23 5RG • Principal Place of Business: Same as registered office
Value undisclosed
Provision of Window Cleaning Services across all Barts Health NHS Trust five hospital sites.<br/><br/>The duration of the contract is 12 months, subject to the right of the Trust (at its sole discretion) to exercise its right to extend the Contract by up to a further 12 months. The maximum length of the contract is therefore 24 months.
Value undisclosed
CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.
Value undisclosed
Barts is putting in place a contract agreement with Place Group Ltd to provide a range of facilities management solutions, principally works and including services, products and support including catering, cleaning, security, grounds maintenance, mechanical and electrical engineering services. Place Group Ltd will be expected to manage, deliver, maintain and integrate competing sub-contractors to ensure choice, best value and seamless inter-operability in each category.
Value undisclosed
Contract for the provision of an outsources Employee Assistance Programme as part of a package or Employee Wellbeing Services provided to Trust staff.
Value undisclosed
To provide, manage and maintain a resilient, reliable and secure network (LAN and WLAN based on the SDA-enabled Cisco design) for all staff at Barts Health whether on an acute site, outpatient site, operational site, out in the community or from home.
Value undisclosed
To provide, manage and maintain a resilient, reliable and secure network (LAN and WLAN based on the SDA-enabled Cisco design) for all staff at Barts Health whether on an acute site, outpatient site, operational site, out in the community or from home.
Value undisclosed